CLOV · Nasdaq · Healthcare · Healthcare Plans
Next earnings: November 3, 2026
$4.34-3.3%Sep 28 close
Clover Health Investments, Corp. is the 9th largest of 11 graded companies. Showing 5 of them, including CLOV itself.
| Company | Grade | Market value | Revenue | Profit margin | Free cash flow | Price to earnings |
|---|---|---|---|---|---|---|
| UnitedHealth Group IncorporatedUNH | B | $339.1B | $450.1B | 3.1% | $23.6B | 24.30 |
| CVS Health CorporationCVS | B | $112.4B | $415.1B | 1.2% | $11.8B | 23.12 |
| Elevance Health, Inc.ELV | B | $85.5B | $201.1B | 2.5% | $6.3B | 17.47 |
| The Cigna GroupCI | B | $71.8B | $282.4B | 2.3% | — | 11.24 |
| Clover Health Investments, Corp.CLOV | A- | $2.3B | $2.5B | -0.7% | $74.2M | — |
A blank price-to-earnings means a loss, not a missing figure — the ratio has no meaning when there are no earnings to divide by, and printing a negative one would make the least profitable company look the cheapest.
Grades are trailing twelve months from each company’s own SEC filings, so they move only when a company files. Every column is computed by the same code that graded Clover Health Investments, Corp. on the overview — nothing here comes from a data vendor’s own ratios.
Industry membership is not a judgement about how similar two businesses are. It groups companies by what they are classified as, which is a starting point for comparison rather than a claim that they compete.
6 more healthcare plans companies
Graded on the same five checks, from their own SEC filings.